Gene: SPARC
Official Full Name: secreted protein acidic and cysteine richprovided by HGNC
Gene Summary: This gene encodes a cysteine-rich acidic matrix-associated protein. The encoded protein is required for the collagen in bone to become calcified but is also involved in extracellular matrix synthesis and promotion of changes to cell shape. The gene product has been associated with tumor suppression but has also been correlated with metastasis based on changes to cell shape which can promote tumor cell invasion. Three transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jun 2015]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO04706 | SPARC Knockout cell line (HeLa) | Human | SPARC | 1:3~1:6 | Negative | Online Inquiry |
KO04707 | SPARC Knockout cell line (HCT 116) | Human | SPARC | 1:2~1:4 | Negative | Online Inquiry |
KO04708 | SPARC Knockout cell line (HEK293) | Human | SPARC | 1:3~1:6 | Negative | Online Inquiry |
KO04709 | SPARC Knockout cell line (A549) | Human | SPARC | 1:3~1:4 | Negative | Online Inquiry |
SPARC Gene Knockout Cell Lines represent a powerful tool in molecular biology, specifically designed to elucidate the functional significance of the SPARC gene (Secreted Protein Acidic and Rich in Cysteine). These engineered cell lines exhibit a complete knockout of the SPARC gene, enabling researchers to investigate the gene's role in various cellular processes, including cell adhesion, migration, and proliferation. By effectively nullifying the expression of SPARC, these cell lines facilitate detailed studies on cellular dynamics and interactions pertinent to cancer research, wound healing, and tissue engineering.
The SPARC protein is known to interact with extracellular matrices and modulate cell signaling pathways, impacting not only development but also disease progression. By utilizing SPARC Gene Knockout Cell Lines, scientists can employ techniques such as Western blotting, RT-PCR, and in vivo assays to unravel the mechanistic pathways affected by SPARC deletion. This functional analysis is crucial for understanding how SPARC contributes to tumor microenvironments, fibrosis, and other pathophysiological conditions.
A primary advantage of our SPARC Gene Knockout Cell Lines is their reproducibility and robustness, which ensures consistent results across experiments. Unlike traditional methods involving genetic silencing, which may yield partial knockdown, these cell lines provide a complete knockout, allowing for clearer insights into gene function. Additionally, they are compatible with a variety of assays, enhancing their utility across multiple research disciplines.
For researchers and clinicians, these knockout cell lines represent an invaluable resource for dissecting the role of SPARC in health and disease. The potential applications range from basic research to drug development and personalized medicine strategies, where understanding gene function is key to advancing therapeutic approaches.
Our company is committed to providing high-quality biological products that empower scientific discovery. With a focus on precision engineering and validated workflows, we ensure that our SPARC Gene Knockout Cell Lines meet the highest standards of reliability and performance, facilitating groundbreaking research and innovative clinical applications.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.